JP2006511465A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511465A5
JP2006511465A5 JP2004532625A JP2004532625A JP2006511465A5 JP 2006511465 A5 JP2006511465 A5 JP 2006511465A5 JP 2004532625 A JP2004532625 A JP 2004532625A JP 2004532625 A JP2004532625 A JP 2004532625A JP 2006511465 A5 JP2006511465 A5 JP 2006511465A5
Authority
JP
Japan
Prior art keywords
saccharide
modified capsular
modified
capsular saccharide
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004532625A
Other languages
English (en)
Japanese (ja)
Other versions
JP5268222B2 (ja
JP2006511465A (ja
Filing date
Publication date
Priority claimed from GBGB0220198.6A external-priority patent/GB0220198D0/en
Application filed filed Critical
Publication of JP2006511465A publication Critical patent/JP2006511465A/ja
Publication of JP2006511465A5 publication Critical patent/JP2006511465A5/ja
Application granted granted Critical
Publication of JP5268222B2 publication Critical patent/JP5268222B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004532625A 2002-08-30 2003-09-01 改変された糖類、それらの結合体、およびそられの製造 Expired - Fee Related JP5268222B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0220198.6 2002-08-30
GBGB0220198.6A GB0220198D0 (en) 2002-08-30 2002-08-30 Modified saccharides,conjugates thereof and their manufacture
PCT/IB2003/004194 WO2004019992A1 (en) 2002-08-30 2003-09-01 Modified saccharides, conjugates thereof, and their manufacture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011228229A Division JP5314745B2 (ja) 2002-08-30 2011-10-17 改変された糖類、それらの結合体、およびそられの製造

Publications (3)

Publication Number Publication Date
JP2006511465A JP2006511465A (ja) 2006-04-06
JP2006511465A5 true JP2006511465A5 (enExample) 2006-10-05
JP5268222B2 JP5268222B2 (ja) 2013-08-21

Family

ID=9943241

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004532625A Expired - Fee Related JP5268222B2 (ja) 2002-08-30 2003-09-01 改変された糖類、それらの結合体、およびそられの製造
JP2011228229A Expired - Fee Related JP5314745B2 (ja) 2002-08-30 2011-10-17 改変された糖類、それらの結合体、およびそられの製造

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011228229A Expired - Fee Related JP5314745B2 (ja) 2002-08-30 2011-10-17 改変された糖類、それらの結合体、およびそられの製造

Country Status (16)

Country Link
US (2) US8895516B2 (enExample)
EP (1) EP1534342B1 (enExample)
JP (2) JP5268222B2 (enExample)
CN (2) CN101863998B (enExample)
AT (1) ATE319481T1 (enExample)
AU (1) AU2003260921B2 (enExample)
BR (1) BR0314089A (enExample)
CA (1) CA2497167C (enExample)
DE (1) DE60303961T2 (enExample)
DK (1) DK1534342T3 (enExample)
ES (1) ES2260682T3 (enExample)
GB (1) GB0220198D0 (enExample)
MX (1) MXPA05002315A (enExample)
NZ (1) NZ538703A (enExample)
RU (2) RU2005108992A (enExample)
WO (1) WO2004019992A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
US20070258986A1 (en) * 2003-11-19 2007-11-08 Govt of the US as represented by the secretary, Targeted Delivery System for Bioactive Agents
NZ563940A (en) 2005-05-06 2010-11-26 Novartis Vaccines & Diagnostic Immunogens for meningitidis-A vaccines comprising oligosaccharides linked by a phosphonate
CN103251940A (zh) 2005-12-22 2013-08-21 葛兰素史密丝克莱恩生物有限公司 疫苗
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
WO2010027499A2 (en) 2008-09-05 2010-03-11 University Of Massachusetts Medical School Methods, compositions and vaccines relating to neisseria meningitidis antibodies
TWI505834B (zh) * 2009-06-22 2015-11-01 Wyeth Llc 組合物及製備金黃色葡萄球菌血清型5及8莢膜多醣結合物之免疫原性組合物之方法
BRPI1015567A2 (pt) 2009-06-22 2021-08-31 Wyeth Llc Composições imunogênicas de antígenos de staphylococcus aureus
MX345967B (es) * 2009-10-30 2017-02-28 Novartis Ag Purificacion de sacaridos capsulares de staphylococcus aureus tipo 5 y tipo 8.
PL3831406T3 (pl) 2010-08-23 2024-09-09 Wyeth Llc Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
RU2546873C2 (ru) 2010-09-10 2015-04-10 УАЙТ ЭлЭлСи Нелипидизированные варианты антигенов neisseria meningitidis orf2086
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY167723A (en) 2012-03-09 2018-09-21 Pfizer Neisseria meningitidis compositions and methods thereof
CN102861326A (zh) * 2012-09-19 2013-01-09 天津康希诺生物技术有限公司 流脑多糖-蛋白质缀合疫苗及制备方法
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
EP4098276A1 (en) 2013-09-08 2022-12-07 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
ES2930318T3 (es) 2014-02-14 2022-12-09 Pfizer Conjugados glucoproteicos inmunogénicos
US10888611B2 (en) 2015-02-19 2021-01-12 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2017158480A1 (en) * 2016-03-15 2017-09-21 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. Novel polysaccharide-protein conjugates and process to obtain thereof
AU2017321863B2 (en) 2016-09-02 2024-07-11 Sanofi Vaccines US Inc. Neisseria meningitidis vaccine
PE20191107A1 (es) 2017-01-31 2019-08-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos
CA3050120A1 (en) * 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
US11389540B2 (en) 2017-09-07 2022-07-19 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
WO2020182635A1 (en) * 2019-03-08 2020-09-17 Glaxosmithkline Biologicals Sa Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2427341A1 (fr) * 1978-06-02 1979-12-28 Delalande Sa Nouveaux derives aminoglycosidiques hemisynthetiques, leur procede de preparation et leur application en therapeutique
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides
WO1995029927A2 (en) * 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
ATE451124T1 (de) * 1997-01-21 2009-12-15 Sanofi Pasteur Polysaccharid-peptid-konjugate
CA2266718C (en) * 1997-08-08 2007-05-22 Behringwerke Aktiengesellschaft Polysaccharide conjugates of biomolecules
US5929049A (en) * 1997-08-08 1999-07-27 Dade Behring Marburg Gmbh Polysaccharide conjugates of biomolecules
US5952454A (en) * 1997-12-12 1999-09-14 The United States Of America As Represented By The Department Of Health And Human Services Linking compounds useful for coupling carbohydrates to amine-containing carriers
WO2003080678A1 (en) * 2002-03-26 2003-10-02 Chiron Srl Modified saccharides having improved stability in water
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture

Similar Documents

Publication Publication Date Title
JP2006511465A5 (enExample)
CA2497167A1 (en) Modified saccharides, conjugates thereof, and their manufacture
JP2005526153A5 (enExample)
CA2480389A1 (en) Modified saccharides having improved stability in water
JP2010132925A5 (enExample)
KR102003138B1 (ko) 신규한 글리칸 접합체 및 그의 용도
JP2012017342A5 (enExample)
CN104703978B (zh) 化合物的盐和固体形式及其组合物和使用方法
JP3773153B2 (ja) シアル酸誘導体
EP3952917A1 (en) Programmable polymeric drugs
JP2010515718A5 (enExample)
CA2657483A1 (en) Macrolide synthesis process
RU2758090C2 (ru) Новые конъюгаты полисахарида с белком и способ их получения
WO2016050209A1 (zh) 一种异官能化聚乙二醇衍生物、制备方法及其生物相关物质
CN1163895A (zh) 新的用于治疗肿瘤和炎症疾病的前药
US20130116423A1 (en) Synthetic Oligosaccharides for Staphylococcus Vaccine
TW201343662A (zh) 醣類-醣脂類結合性疫苗
AU2018235063A1 (en) Glycopolymers sequestering carbohydrate-binding proteins
US8618096B2 (en) Prodrug compositions and methods for using the same in treating cancer and malaria
CN111902162A (zh) 双亚氨基生物素化合物的药物递送用的用途
CN102803228A (zh) 酸不稳定触发子单元
US20140234364A1 (en) Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis
JP2010540488A5 (enExample)
CN1205217C (zh) 核糖-核糖醇-磷酸之寡糖衍生物及含有它们的疫苗
RU2338753C2 (ru) Модифицированные сахариды, имеющие улучшенную стабильность в воде